Markets
Geron Stock Soars 11%, Adding $64 Million, As Rytelo Sales Push It To A Profit
The blood-cancer drugmaker posted a small third-quarter profit on Rytelo growth and trimmed its 2026 operating expense guidance.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Markets
The blood-cancer drugmaker posted a small third-quarter profit on Rytelo growth and trimmed its 2026 operating expense guidance.
Markets
Early customer renewals at lower prices weigh on the near-term outlook, despite 35% revenue growth.
Earnings
Dan Taylor's first call as CEO paired a guidance cut with a cost plan, as prediction-market operators push up media costs.
Markets
The battery developer's shares rebounded after it lowered planned 2026 cash investment and reported $397.6 million in liquidity.
Deals
The water and gas utility still expects its American Water merger to close in the first quarter of 2027, with three settlements awaiting approval.
Markets
The silver miner lifted the bottom of its 2026 output range and trimmed its cost outlook, while warning Keno Hill milling will slow.
Markets
The foodservice distributor held its full-year forecast while independent restaurant volumes outgrew overall cases.
Earnings
Steve Cahillane also said price increases are coming in 2027, with inflation now seen slightly above 5%.
Markets
The Japanese payments firm said its second-quarter margin beat its own projection and lifted its revenue target for the year.
Markets
Management said third-quarter margins in its core shopping business should be the low point, and guided to 13% to 14% fourth-quarter growth.
Markets
The chip designer reported third-quarter sales up 154% and guided higher, yet Needham and Susquehanna cut their price targets.
Markets
The drugmaker kept its 2026 targets as IBSRELA sales rose 23% and its net loss narrowed to $737,000.